Demayo, Bb Boy I .

HRN: 28-31-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
AMPICILLIN 250MG (VIAL)
12/27/2025
01/03/2026
IV
155mg
Q12
PSNB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines